Ebola vaccine (PIKA adjuvant) (Yisheng/USAMRIID)

N/A

Report date: 2026/01/23 11:09:15

Base Information

Drug NameEbola vaccine (PIKA adjuvant) (Yisheng/USAMRIID)
Drug Alias NameN/A
ClassificationVaccines > Application > Prophylactic vaccineVaccines > Development/production technology > Nucleic acid vaccine
Mechanisms of ActionToll like receptor 3 agonists
TargetsToll like receptor 3
Therapy Area/IndicationsHemorrhagic Fever, Ebola
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesMainland China
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaPending
Originator CompaniesLakeShore Biopharma Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesLakeShore Biopharma Co LtdUS Army Medical Research Institute of Infectious Diseases
Active IndicationsN/A
Inactive IndicationsHemorrhagic Fever, Ebola

Other Information

ATC CodeN/A
Related LinksN/A